Search

Recent advances in osteoimmunology have led the focus on the immunomodulatory design of metal–organic framework (MOF)-based porous materials for encouraging bone repair by influencing the immune microenvironment using implanting biomaterials. Despite the growing interest in porous materials, few research studies have been done on how extracellular Sr2+ and Ca2+ loaded in MOFs leads the organism toward optimal osteogenesis. In this study, in vitro evaluations showed that both Sr2+ and Ca2+ nanoparticles have a dual effect, stimulating matrix secretion by osteoblasts while suppressing matrix resorption by osteoclasts. Sr2+ significantly increased RUNX2 transcriptional activity and phosphorylation in gene expression evaluation. On day seven, hBMSC cells on HKUST-1@CaNPs/SrNPs showed a significant increase in collagen gene expression compared to HKUST-1@CaNPs/SrNPs@PEG, indicating a high level of proliferation and differentiation. At the same time, the HKUST-1@SrNPs hBMSC cells expressed the RUNX2 gene at a much higher level than the other groups. ALP activity was measured on days 7 and 14 of culture to see how it compares to more extended incubation periods. As the culture time for HKUST-1@SrNPs and HKUST-1@CaNPs/SrNPs was extended from 7 to 14 days, the ALP activity was shown to rise. Findings indicated that HKUST-1@CaNPs/SrNPs improved hBMSC osteogenic differentiation potential. In conclusion, HKUST-1@CaNPs/SrNPs could show promising results for bone tissue engineering.

Summary: Background: The objective of this study is to investigate the trends of exposure and burden attributable to the four main metabolic risk factors, including high systolic blood pressure (SBP), high fasting plasma glucose (FPG), high body-mass index (BMI), and high low-density lipoproteins cholesterol (LDL) in North Africa and the Middle East from 1990 to 2019. Methods: The data were retrieved from Global Burden of Disease Study 2019. Summary exposure value (SEV) was used for risk factor exposure. Burden attributable to each risk factor was incorporated in the population attributable fraction to estimate the total attributable deaths and disability-adjusted life-years (DALYs). Findings: While age-standardized death rate (ASDR) attributable to high-LDL and high-SBP decreased by 26.5% (18.6–35.2) and 23.4% (15.9–31.5) over 1990–2019, respectively, high-BMI with 5.1% (−9.0–25.9) and high-FPG with 21.4% (7.0–37.4) change, grew in ASDR. Moreover, age-standardized DALY rate attributed to high-LDL and high-SBP declined by 30.2% (20.9–39.0) and 25.2% (16.8–33.9), respectively. The attributable age-standardized DALY rate of high-BMI with 8.3% (−6.5–28.8) and high-FPG with 27.0% (14.3–40.8) increase, had a growing trend. Age-standardized SEVs of high-FPG, high-BMI, high-SBP, and high-LDL increased by 92.4% (82.8–103.3), 76.0% (58.9–99.3), 10.4% (3.8–18.0), and 5.5% (4.3–7.1), respectively. Interpretation: The burden attributed to high-SBP and high-LDL decreased during the 1990–2019 period in the region, while the attributable burden of high-FPG and high-BMI increased. Alarmingly, exposure to all four risk factors increased in the past three decades. There has been significant heterogeneity among the countries in the region regarding the trends of exposure and attributable burden. Urgent action is required at the individual, community, and national levels in terms of introducing effective strategies for prevention and treatment that account for local and socioeconomic factors. Funding: Bill & Melinda Gates Foundation.

COVID-19, which was first spread in China in 2019 and consequently spread worldwide, is caused by the SARS-CoV-2. Today, various carbon-based nanomaterials such as graphene, graphene oxide, carbon dots, and carbon nanotubes have been explored for the specific detection and targeted inhibition/inactivation of SARS-CoV-2 due to their great surface chemical structures, easy to-functionalization, biocompatibility, and low toxicity. According to exclusive inherent properties, carbon-based nanomaterials are promising candidates for targeted antiviral drug delivery and the inhibitory effects against pathogenic viruses based on photothermal effects or reactive oxygen species (ROS) formation. These high-stability nanomaterials exhibited unique physicochemical properties, providing efficient nanoplatforms for optical and electrochemical sensing and diagnostic applications with high sensitivity and selectivity. Up to now, these materials have been used for the fabrication of diagnostic kits, different types of personal protective equipment (PPE) such as anti-viral masks, vaccines, self-cleaning surfaces, and other subjects. This review article explores the most recent developments in carbon-based nanomaterials' diagnostic and therapeutic potential towards SARS-CoV-2 detection and inhibition, different mechanisms, challenges and benefits of the carbon-based nanomaterials.

In this work, for the first time, different forms of nanocomposites based on rGO and MWCNT were prepared in conjoining with the bioactive glass (BioGlass). In the carbonic layers, a highly toxic nanoparticle, CoNi2S4, was intercalated, and the role of this nanoparticle in the alkaline phosphatase activity, relative cell viability on different cell lines, and also the effect on the cell walls and cell morphologies were investigated. From another perspective, the ability of the chemotherapy drug loading to the prepared nanocomposites was investigated, and the use of leaf extracts was thought of as a green method to lower the cytotoxicity and regulate the genotoxicity of the generated nanocomposite. The results showed that the nanocomposites without the chemotherapy drug had higher relative cell viability than the drug-loaded nanocomposites. The relative cell viability also reached a new range when the leaf extract was applied to the surface. Thus, utilizing a leaf extract to raise the relative cell viability would be considered a novel and unique technique. From another perspective, the ALP activity of the nanocomposites, along with the toxic nanoparticles, showed promising results with the appropriate cell-seeded factors. In this regard, the morphology of the cells and the nanocomposites after seeding and treatment with each other on the hBMSCs and HEK-293 cell lines were investigated. The findings demonstrated that the shape of the nanocomposites has significantly changed in morphology as a result of the cell wall degradations and aggregations; the treated HEK-293 cell line's morphology, however, shows no significant changes after 4 h.

Early diagnosis is essential for the effective illness treatment, but traditional diagnostic approaches inevitably have major downsides. Recent advancements in nanoparticle-based biosensors have created new opportunities for accelerating diagnosis. High surface area, exceptional sensitivity, high specificity, and optical characteristics of metal and metal oxide nanoparticles have made it possible to detect a variety of health conditions and diseases immediately, including cancer, viral infection, biomarkers, and in-vivo imaging. Metal nanoparticles may be produced in a variety of ways, enabling the creation of innovative tools for chemical and biological sensing targets. The utilization of various metal nano-formulations, metal oxide nanoplatforms, and their composites in the early identification of illnesses is reported and summarized in this review. Additionally, the challenging corners in the use of metal oxide-based nano-scale diagnostic technologies in clinical applications are highlighted. The current work is believed to serve as a roadmap for in-depth research on inorganic nanomedicine, both in-vitro and in-vivo diagnosis of diseases and illnesses, especially pandemic infections like COVID-19.

This review highlights using nanotechnology in increasing the bioavailability of AP (Apigenin) to enhance its therapeutic efficacy in breast cancer treatment. Breast cancer is one of the most leading causes of cancer death in women both in developed and developing countries. According to several epidemiological and clinical trial studies that indicate progestin-stimulated breast cancer in post-menopausal women; it is necessary to determine compounds to suppress or attenuate the tumor-promoting effects of progestins in breast cells. For this purpose, using the natural anti-progestins, including AP compared with the chemical ones could be significantly effective due to the lack of toxicities and contradiction effects. However, AP is categorized as a Class II drug of Biopharmaceutical Classification System with low solubility in water which limited its therapeutic effects. Therefore, nanotechnology due to the presentation of remarkable properties has overcome this limitation through enhanced the solubility and bioavailability of AP. In this regard, various nanocarriers such as nanocrystals, micelles, liposomes, PLGA, etc., have highlighted the significantly increased bioavailability and therapeutic efficacy of AP. Therefore, we will focus on the anticancer effects of AP in breast cancers, including involved mechanisms, the chemistry of AP and its bioavailability, finally different nanostructure systems to enhance the bioavailability of AP.